Sfoglia per Autore
Multitarget Drugs: No-Donor Doxorubicins
2015-01-01 Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto
Screening for potential hazard effects from a multitarget anthracycline on the cardiovascular system
2015-01-01 Durante, M.; Frosini, M.; Fusi, F.; Maestrini, V.; Gorelli, B.; Valoti, M.; Chegaev, K.; Saponara, S.
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion
2015-01-01 Fausto Chiazza;Konstantin Chegaev;Mara Rogazzo;Juan C. Cutrin;Elisa Benetti;Loretta Lazzarato;Roberta Fruttero;Massimo Collino
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease
2015-01-01 Chegaev, Konstantin; Federico, Antonella; Marini, Elisabetta; Rolando, Barbara; Fruttero, Roberta; Morbin, Michela; Rossi, Giacomina; Fugnanesi, Valeria; Bastone, Antonio; Salmona, Mario; Badiola, Nahuai B.; Gasparini, Laura; Cocco, Sara; Ripoli, Cristian; Grassi, Claudio; Gasco, Alberto
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin.
2015-01-01 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
MITOCHONDRIAL-TARGETING NITROOXYDOXORUBICIN: EFFECTS ON P-GLYCOPROTEIN AND ASSESSMENT OF THEIR VASCULAR EFFECTS
2014-01-01 Frosini Maria; Maestrini Vanessa; Neri Annalisa; Santulli Chiara; Brizi Claudia; Chegaev Konstantin; Riganti Chiara; Sgaragli Giampietro; Colabufo Nicola Antonio; Saponara Simona
Nitric oxide donor-doxorubicins as mdr reversing agents
2014-01-01 E.Gazzano; K. Chegaev; Pedrini I.; Kopecka J. Rolando B.;Fruttero ; Arpicco S.; Ghigo D. Riganti C.
Novel NO-donor Doxorubicins
2014-01-01 Daniela Cortese; Konstantin Chegaev; Chiara Riganti; Barbara Rolando; Roberta Fruttero; Alberto Gasco.
Leishmanicidal Activity of Novel Synthetic Furoxan and Benzofuroxan Derivatives
2014-01-01 L. A. Dutra;L. De Almeida;T. G. Passalacqua;J. S. Reis;F. A. E. Torres;I. Martinez;R. G. Peccinini;C. Man Chin;K. Chegaev;S. Guglielmo;R. Fruttero;M. A. S. Graminha;J. L. Dos Santos
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells
2014-01-01 Isabella Pedrini;Elena Gazzano;Konstantin Chegaev;Barbara Rolando;Alessandro Marengo;Joanna Kopecka;Roberta Fruttero;Dario Ghigo;Silvia Arpicco;Chiara Riganti
SCREENING FOR POTENTIAL HAZARD EFFECTS FROM MULTITARGET ANTHRACYCLINE ON THE CARDIOVASCULAR SYSTEM
2014-01-01 S. Saponara; M. Durante; M. Frosini; B. Gorelli; M. Valoti; K. Chegaev; G. Sgaragli; F. Fusi
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents
2014-01-01 Konstantin Chegaev; Loretta Lazzarato; Yasinalli Tamboli; Donatella Boschi; Marco Blangetti; Andrea Scozzafava; Fabrizio Carta; Emanuela Masini; Roberta Fruttero; Claudiu T. Supuran; Alberto Gasco
Preparation and characterization of liposomes containing a new anthracycline derivative.
2013-01-01 I. Pedrini; E Gazzano; S. Arpicco; C. Riganti; B. Rolando; K Chegaev; R. Fruttero; A. Gasco
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat
2013-01-01 F. Chiazza; M. Rogazzo; E. Benetti; K. Chegaev; A. Di Stilo; R. Fruttero; J.C. Cutrin;R . Fantozzi; M. Collino
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.
2013-01-01 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY
2013-01-01 Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco
Doxorubicin-antioxidant multitarget drugs
2013-01-01 K Chegaev; C Riganti; B Rolando; L Lazzarato; E Gazzano; S Guglielmo; D Ghigo; R Fruttero; A Gasco
PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING A NEW ANTHRACYCLINE DERIVATIVE
2013-01-01 Isabella Pedrini; Elena Gazzano; Silvia Arpicco; Chiara Riganti; Barbara Rolando; Konstantin Chegaev; Roberta Fruttero; Alberto Gasco
Screening for potential hazard effects from multitarget anthracyclines on vasculature
2013-01-01 M. Durante; A. Neri; M. Frosini; M. Valoti; G. Sgaragli; F. Fusi; K. Chegaev; S. Saponara
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance.
2013-01-01 Chiara Riganti; Barbara Rolando; Joanna Kopecka; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Multitarget Drugs: No-Donor Doxorubicins | 2015 | Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto | |
| Screening for potential hazard effects from a multitarget anthracycline on the cardiovascular system | 2015 | Durante, M.; Frosini, M.; Fusi, F.; Maestrini, V.; Gorelli, B.; Valoti, M.; Chegaev, K.; Saponara, S. | |
| A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion | 2015 | Fausto Chiazza;Konstantin Chegaev;Mara Rogazzo;Juan C. Cutrin;Elisa Benetti;Loretta Lazzarato;Roberta Fruttero;Massimo Collino | |
| NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease | 2015 | Chegaev, Konstantin; Federico, Antonella; Marini, Elisabetta; Rolando, Barbara; Fruttero, Roberta; Morbin, Michela; Rossi, Giacomina; Fugnanesi, Valeria; Bastone, Antonio; Salmona, Mario; Badiola, Nahuai B.; Gasparini, Laura; Cocco, Sara; Ripoli, Cristian; Grassi, Claudio; Gasco, Alberto | |
| Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. | 2015 | Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S. | |
| MITOCHONDRIAL-TARGETING NITROOXYDOXORUBICIN: EFFECTS ON P-GLYCOPROTEIN AND ASSESSMENT OF THEIR VASCULAR EFFECTS | 2014 | Frosini Maria; Maestrini Vanessa; Neri Annalisa; Santulli Chiara; Brizi Claudia; Chegaev Konstantin; Riganti Chiara; Sgaragli Giampietro; Colabufo Nicola Antonio; Saponara Simona | |
| Nitric oxide donor-doxorubicins as mdr reversing agents | 2014 | E.Gazzano; K. Chegaev; Pedrini I.; Kopecka J. Rolando B.;Fruttero ; Arpicco S.; Ghigo D. Riganti C. | |
| Novel NO-donor Doxorubicins | 2014 | Daniela Cortese; Konstantin Chegaev; Chiara Riganti; Barbara Rolando; Roberta Fruttero; Alberto Gasco. | |
| Leishmanicidal Activity of Novel Synthetic Furoxan and Benzofuroxan Derivatives | 2014 | L. A. Dutra;L. De Almeida;T. G. Passalacqua;J. S. Reis;F. A. E. Torres;I. Martinez;R. G. Peccinini;C. Man Chin;K. Chegaev;S. Guglielmo;R. Fruttero;M. A. S. Graminha;J. L. Dos Santos | |
| Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells | 2014 | Isabella Pedrini;Elena Gazzano;Konstantin Chegaev;Barbara Rolando;Alessandro Marengo;Joanna Kopecka;Roberta Fruttero;Dario Ghigo;Silvia Arpicco;Chiara Riganti | |
| SCREENING FOR POTENTIAL HAZARD EFFECTS FROM MULTITARGET ANTHRACYCLINE ON THE CARDIOVASCULAR SYSTEM | 2014 | S. Saponara; M. Durante; M. Frosini; B. Gorelli; M. Valoti; K. Chegaev; G. Sgaragli; F. Fusi | |
| Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents | 2014 | Konstantin Chegaev; Loretta Lazzarato; Yasinalli Tamboli; Donatella Boschi; Marco Blangetti; Andrea Scozzafava; Fabrizio Carta; Emanuela Masini; Roberta Fruttero; Claudiu T. Supuran; Alberto Gasco | |
| Preparation and characterization of liposomes containing a new anthracycline derivative. | 2013 | I. Pedrini; E Gazzano; S. Arpicco; C. Riganti; B. Rolando; K Chegaev; R. Fruttero; A. Gasco | |
| Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat | 2013 | F. Chiazza; M. Rogazzo; E. Benetti; K. Chegaev; A. Di Stilo; R. Fruttero; J.C. Cutrin;R . Fantozzi; M. Collino | |
| Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. | 2013 | Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo | |
| NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY | 2013 | Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco | |
| Doxorubicin-antioxidant multitarget drugs | 2013 | K Chegaev; C Riganti; B Rolando; L Lazzarato; E Gazzano; S Guglielmo; D Ghigo; R Fruttero; A Gasco | |
| PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING A NEW ANTHRACYCLINE DERIVATIVE | 2013 | Isabella Pedrini; Elena Gazzano; Silvia Arpicco; Chiara Riganti; Barbara Rolando; Konstantin Chegaev; Roberta Fruttero; Alberto Gasco | |
| Screening for potential hazard effects from multitarget anthracyclines on vasculature | 2013 | M. Durante; A. Neri; M. Frosini; M. Valoti; G. Sgaragli; F. Fusi; K. Chegaev; S. Saponara | |
| Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. | 2013 | Chiara Riganti; Barbara Rolando; Joanna Kopecka; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile